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Abstract 
 
 Plants are a common source of new medicinal compounds.  This paper is focused on 
documenting the safety of one such species, Artemisia annua L., as an antimalarial treatment. Malaria 
is a dangerous disease especially common in tropical areas, which are quite often developing countries. 
Medicinal use of A. annua is known to have occurred as early as 168 B.C. In China where it was used 
to treat multiple ailments. In more modern history, an extract of the plant called artemisinin was 
recognized as an effective antimalarial medicine.  However, recent research showed that a treatment 
involving consumption of the whole plant material not only has greater efficacy but also reduces the 
risk of the parasites developing resistance.  It is intended that the dried leaves be used as an orally or 
rectally administered tablet made up of ground and compressed dried leaf material. In order to aid in 
determining the safety of using the dried leaves of A. annua as a treatment for malaria, information 
regarding the plant’s safety was acquired and collated in the form of an FDA GRAS proposal. GRAS is 
an acronym used by the U.S. Food and Drug Administration that represents “Generally Regarded As 
Safe” and means that a substance is safe enough to be excluded from food additive requirements.  By 
structuring this report in the form of a GRAS proposal, it can reasonably be expected that the breadth 
and validity of the reported information will be sufficient to demonstrate the safety of A. annua. 
Information regarding safety of A. annua was obtained from a number of sources including books, 
scientific papers, government documents, and internet web sites. Assessment of reports of the plant's 
chemical composition showed that no compound naturally present in A. annua would produce ill side 
effects given the anticipated level of consumption. A. annua, like many plants, can absorb heavy metals 
from the soil, and their over accumulation can be harmful. That being said, A. annua is currently sold 
by multiple companies as a dietary supplement in the United States and is also eaten as part of salads in 
some Asian countries. It is also considered to be a safe plant according to Dr. James A. Duke, an 
American botanist and author of numerous publications. In conclusion, Artemisia annua L. is safe 
enough to satisfy the GRAS rating and be used in the future as an antimalarial treatment made up of the 
whole plant material. 
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1.0 Description 
Artemisia annua L. is an annual plant that has a native range from Eastern Europe all the 
way to Vietnam, but has now naturalized over much of the world (Royal Botanical Gardens). It 
has a single woody stem that grows about one meter in height. The plant has smaller branches 
with green leaves that are divided into three leaflets. The flowers grow in small buds with an 
outer green layer and the inside petals are usually yellow (Royal Botanical Gardens). The leaves, 
floral buds and flowers also have glandular trichomes where the drug artemisinin is produced 
and stored (Lommen et al. 2006). 
1.1 History 
The earliest known use of A. annua is as early as 168 B.C. in China where it is called 
Qing Hao (Hongwen and Shouming, 2002). It was used for treating “hemorrhoids, lice, wounds, 
boils, sores, ‘lingering heat in joints and bones’ as well as ‘exhaustion due to heat/fevers’” (Hsu, 
2006a). The last two ailments are common symptoms of malaria, so the plant was likely used to 
treat malaria long before modern times (Hongwen and Shouming, 2002). According to the 
ancient Chinese Materia Medica, the plant was prepared by soaking it in water and then wringing 
it out, this would expel the juice from the plant into the water, which was then simply ingested in 
its entirety (Hsu, 2006b). 
1.2 Modern Research 
A. annua is also a vital medicinal herb in modern medicine primarily for 
extraction of artemisinin, one of its main phytochemicals. Artemisinin is 
a sesquiterpene lactone with a peroxy group that is produced in the 
glandular trichomes of the plant (Ferreira and Janick 1995). The peroxy (Desrosiers and Weathers, 2016) 
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group has been determined to be an essential for therapeutic activity (Li, 2012). Artemisinin was 
isolated from A. annua by Chinese scientists and has proven successful at treating malaria. The 
drug is now delivered as part of a combination therapy (ACT, artemisinin combination therapy) 
where an artemisinin derivative is combined with another antimalarial drug, e.g. artemether + 
lumafantrine in Coartem® (Nosten and White, 2007; Wilairatana et al. 2002). For discovery of 
artemisinin, the lead of the project, Tu Youyou, was one of the recipients of the 2015 Nobel Prize 
in Medicine.  The Chinese effort started as Project 523, a secret military program to find a cure 
for malaria, which was a major cause of death in China’s southern provinces (Miller and Su, 
2011).  The project was split into two groups, one to develop synthetic compounds, and the other 
to examine traditional Chinese medicine.  The second group, led by Tu Youyou, screened more 
than one hundred different herbs until inspired by a text called Emergency Prescriptions Kept up 
one’s Sleeve by Ge Hong, written in 340 A.D (Hsu, 2006a).  The text called for preparing the 
plant using only low heat as opposed to more common herbal teas or infusions, which used 
boiling water. The research team tested its effectiveness on mice and monkeys with success, until 
moving onto a human clinical trial in August 1972 where twenty-one patients were cured of 
malaria (Hsu, 2006b).  Due to the military origins of the project, the researchers were unable to 
share their findings with non-Chinese scientists until after Project 523’s eventual end in 1981. 
The Walter Reed Army Institute of Research was the first to produce artemisinin outside of 
China and lead the way for its commercial use (Weina, 2008). 
1.3 Production 
Artemisinin can be produced both naturally and semi-synthetically although the natural 
method is far more common.  Synthetic production of artemisinin is done through the use of 
genetically engineered yeast, which are cultured in large bioreactors and produce artemisinic 
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acid, a precursor to artemisinin (Peplow 2016).  Natural production involves growing, 
harvesting, and processing A. annua from which artemisinin is extracted. The best time to 
harvest the plant is at the start of flowering when artemisinin content in the leaves is highest 
(WHO, 2005). There are other factors such as geographical conditions, harvesting time, and 
fertilizer application that can also affect production (WHO, 2005). The highest artemisinin 
content that can be expected is 1-2% of dry weight of leaf (WHO, 2005).  After the crop is 
harvested, it is cleaned of foreign matter, sprayed with water, and cut into sections.  The plants 
are then dried either in the sun, shade, or through the use of an oven.  The branches are finally 
shaken or struck to release the leaves so that they may be collected (WHO, 2005). There are 
several viable methods for extraction of artemisinin from A. annua and is most commonly done 
with solvents such as supercritical carbon dioxide or hexane, which are relatively cost effective 
methods (Lapkin et al. 2006). 
1.4 Malaria 
Malaria is one of the world’s most problematic diseases in tropical areas, especially in 
developing countries. In 2015 for example, there was an 
estimated 214 million cases worldwide with 
approximately 438,000 deaths (CDC, 2016a). It is caused 
by several species of parasitic protozoa: Plasmodium 
falciparum, P. vivax, P. ovale, and P. malariae (Wilairatana 
et al. 2002). The parasites are spread by mosquitos that infect humans through a bite.  The 
Plasmodium, in the form of sporozoites, travels through the infected person’s blood stream to the 
liver where they asexually reproduce (Warhurst, 2007). The resulting offspring are merozoites, 
which travel back into the bloodstream, infect red blood cells, and continue to asexually 
(CDC, 2016b) 
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reproduce (Warhurst, 2007).  The blood cell hosts are destroyed by this process. Some of the 
merozoites instead develop into gametocytes, which are then taken up into a new mosquito when 
the human host is bitten again (Warhurst, 2007).  The gametocytes differentiate into male and 
female genders and sexually reproduce in the mosquito, completing the lifecycle.  
Common symptoms of malaria include fever, chills, sweats, headaches, muscles pain, 
nausea, and vomiting (CDC, 2016a). More severe malaria can cause confusion, coma, neurologic 
focal signs, severe anemia, and respiratory difficulties (CDC, 2016a). Pregnant women are of 
particular concern as malarial infection is linked with stillbirths, infant mortality, abortion, and 
low birth rate (Hartman, 2010). The particular benefit of artemisinin has been its effectiveness in 
treating the disease when the parasites have developed resistance to the previous antimalarial 
medications including chloroquine, mefloquine, halofantrine and a combination of quinine and 
tetracycline; artemisnins also do not cause significant side effects like pyrimethamine and 
sulfonamide (Wilairatana et al. 2002). Patients using the latter drugs such as chloroquine and 
may experience stomach pain or nausea and mefloquine can cause seizures, visual disturbances 
and psychosis (CDC, a; CDC, b).  Unfortunately, regular use of artemisinin also is resulting in 
emergence of artemisinin drug resistance. 
1.5 Whole Plant Treatments 
Recent research however, has started to show that consumption of the dried leaves of A. 
annua is actually more effective in the treatment of malaria due to increased bioavailability of 
artemisinin found within the plant and in response to other antimalarial phytochemicals such as 
1,8-cineole, limonene, and flavonoids, that work with artemisinin to be effective against resistant 
parasites (Elfawal et al. 2012; Weathers et al. 2014). Whole plant treatments have been shown to 
be effective against artemisinin resistant parasites potentially because of these additional 
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phytochemicals (Elfawal, 2015). The various active ingredients within the whole leaf material 
means that the treatment is not a mono therapy and resistance will develop slowly, if at all 
(Elfawal et al. 2015). One of the most promising effects of this whole plant treatment is that it 
kills the sexually active gametocytes that survive in the patient even after other treatments have 
cured them from the disease (Wright et al. 2002). These gametocytes can be transmitted into 
mosquitos that have bitten the host, which are then eventually transmitted back into other 
humans; this is how the disease is able to spread despite treatment (Bousema et al. 2006). A. 
annua can even be used to make an essential oil that has shown significant antimicrobial effect 
(Juteau et al. 2002). 
Much of the population that suffers the most from malaria lives in developing countries, 
where antimalarial medications are often difficult to obtain and expensive to purchase if 
available. The higher cost of manufacturing artemisinin medications can place the drug out of 
reach for some patients so a switch to use of much more affordable whole plant treatments could 
provide many more people with access to this life saving medication. 
1.6 GRAS Rating 
“Any substance that is intentionally added to food is a food additive, that is subject to 
pre-market review and approval by FDA, unless the substance is generally recognized, among 
qualified experts, as having been adequately shown to be safe under the conditions of its 
intended use” (FDA GRAS, 2004). 
This official recognition of safety by the FDA is called a GRAS rating (Generally 
Recognized As Safe). The rating would allow for the rated substance to be added to food, or 
otherwise ingested, with fewer restrictions and less difficulty getting review from the FDA. A 
GRAS rating is attained by submitting a report to the FDA what a particular substance should 
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have the rating. The submission includes identity, intended use, manufacture process, historical 
use in food before 1958 and clinical studies showing its safety. 
1.7 Objective 
The goals of this project are to collect information regarding the safety of Artemisia 
annua L. for ingestion and compile it in a format as if for a GRAS submission. Although the 
document will not actually be submitted to the FDA, the material will now be assembled in one 
public location. 
1.8 Methodology 
For a substance to receive a GRAS rating the FDA requires proof that ingestion of the 
substance causes no adverse effects and/or that is has been in long term general use. Common 
acceptance of a substance as GRAS by experts in the field is also relevant information the FDA 
would consider.  In the case of substances used in food before January 1, 1958, experience based 
on common use can also act as evidence.  This means proof of long spread cultural use as food 
would also be applicable.   
There is already a general consensus among experts that A. annua L. is safe for 
consumption in reasonable amounts. It has been used to create herbal teas and infusions in 
traditional and modern Chinese medicine (Räth, 2004). Whole plant matter has been used in 
studies to test for efficacy in treatment of malaria, and it is even listed as GRAS, for use as a 
food additive, in the Handbook of phytochemical constituents of GRAS herbs and other economic 
plants by J. Duke (2001).  Still, as much evidence as possible needs to be gathered to include in 
the notice from sources such as books, scientific journals, and data from the internet.  Besides 
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using library resources, communicating with people from the FDA itself will also be another 
avenue of information. 
The final step of the project will be to collate our combined research into a format fitting 
that of a final GRAS notice. We have determined that A. annua is already qualified for a GRAS 
rating because the entire Artemisia genus is listed as long as the food product is thujone-free 
(Appendix A). Thujone is a monoterpene neurotoxin that can cause death after consumption 
(Cobb, 1922). A. annua is a species that does not contain or produce thujone so it is allowed by 
this restriction. 
 
GRAS Notice 
2.0    GRAS sections 
Necessary elements of an FDA GRAS Notice 
 Introductory information about the submission.* 
 Information about the notifier.* 
 General administrative information.* 
 Intended use. 
 Identity. 
 Method of manufacture. 
 Specifications. 
 Dietary exposure. 
 Self-limiting levels of use. 
 Common use in food before 1958. 
 Comprehensive discussion of the basis for the GRAS determination. 
 Bibliography. 
 Signature 
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*These sections have been determined to not be needed at this time because this notice draft is at 
present only an academic exercise. 
 
2.1    Intended use 
The dried plant leaves and small bits of stem of A. annua L. are intended to be used as a 
medicinal herb for the treatment of malaria. The plant has many possible methods of use 
including as compressed dried leaf tablets, encapsulated dried leaf powder and precisely 
prepared tea infusion all of which are taken orally. The pure drug can also be delivered rectally 
via capsules, although this leads to less effective absorption (Titulaer et al. 1990). Encapsulation 
has not shown a significant decrease in the absorption of artemisinin or flavonoids but some 
foods such as peanut butter did decrease absorption (Desrosiers and Weathers, 2016). The plant 
is intended for consumption by the general population of adults, and children that are infected 
with malaria. Children too young to swallow tablets can ingest the drug via nasogastric tube or 
rectally.  
 
2.2    Identity 
The dried leaf material of A. annua L. is commonly known as “sweet annie, sweet 
wormwood, sweet sagewort, annual mugwort, annual wormwood, or in Chinese, pinyin: 
qinghao” (Weathers, 2015).  A. annua is native to Southeast Asia and China, growing naturally in 
the steppes of Chahar and Suiyuan at about 1000 m above sea level (Ferreira and Janick, 2009). 
The plant has however now been naturalized over much of the world (Royal Botanical Gardens). 
It has a single woody stem that grows about one meter high. It has smaller branches that grow 
green leaves that are divided into three leaflets. The flowers grow in small buds with an outer 
green layer and the inside petals are usually yellow (Royal Botanical Gardens). 
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2.3    Production 
A. annua is grown around the world including Argentina, France, Italy, and China and has 
been naturalized in the United States, it is best suited to open sunny areas with limited rainfall 
(Royal Botanical Gardens). The For extraction of artemisinin, plants are usually grown on 
plantations or small plots, harvested and dried, and then shipped to various sites where the leaves 
are processed to extract the artemisinin (Hongwen and Shouming, 2002). The best time to 
harvest the plant is at the start of flowering when the floral buds have formed and the artemisinin 
content in the leaves is highest (WHO. 2005). There are other factors such as geographical 
conditions, harvesting time, and fertilizer application that can also affect production (WHO, 
2005). The highest artemisinin content that can be expected is 1-2% of dry weight of leaves 
(WHO, 2005). After the crop is harvested, it is cleaned of foreign matter, sprayed with water and 
cut into sections. The plants are then dried either in the sun, shade or through the careful use of 
an oven. The branches are finally shaken or struck to release the leaves so that they can be 
collected (WHO, 2005). The dried leaf material is then crushed into fine powder, mixed so that 
the material is homogenous and pressed into tablets (ICIPE, 2005). The material can also be 
made into capsules, which show no signs of decreasing artemisinin bioavailability, but do mask 
the bitter taste of the leaf material (Desrosiers and Weathers, 2016). Powdered leaf tablets are the 
preferred form for oral ingestion because artemisinin is then more bioavailable, there is greater 
antimalarial efficacy from orally ingested plant material, and there is more resiliency against 
emergence of artemisinin drug resistance (Weathers et al. 2011; Elfawal et al. 2012, 2015).  
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2.4    Chemical Composition 
The chemical composition of A. annua will vary based on the cultivar, soil chemistry, climate 
and season. However, Iqbal et al. (2012) provides an example of the general composition of the 
plant (Table 1). 
 
Table 1: Chemical composition of Artemisia annua leaves (Iqbal et al. 2012) 
 
Contents Amount (% dry weight basis) 
Ash 7.5 
Carbohydrate 8.3 
Fat 6.07 
Fiber 14.2 
Moisture 11.4 
Protein 24.37 mg/100g 
Phytate 140.4 mg/100g 
Total Tannins 0.61 mg/100g 
Tocopherol 2.74 mg/100g 
 
 
The essential oil of A. annua comprises 0.4% to 4.0% of the composition of the leaves by 
weight (Bilia et al. 2014).  The type and concentration of the compounds that make up the oil 
varies widely over geographic regions and can also be affected by the drying temperature 
(Tzenkova et al. 2010). Listed in Table 2 are many of the compounds known to be present in the 
essential oil with an estimated percentage of composition by weight, and, where known, the oral 
LD50 of those components. 
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Table 2: Chemical Composition of Artemisia annua essential oil (Tzenkova et al. 2010; Azimova 
and Glushenkova, 2012) 
 
Compound Estimated 
% of 
Total EO 
Oral LD50 Reference 
Aldehydes 12 N/A  
L-β-Artemisia alcohol 4 N/A  
Tiglate artemisia alcohol N/A N/A  
Artemisia ketone 8.45 N/A  
Artemisia triene 0.25 N/A  
Borneol <0. Mouse 3720 mg/kg (Science Lab 2013b) 
α-Bourbonene <0.1 N/A  
Cadinene 1.03 Rat >5000 mg/kg (Vigon. 2015a) 
Camphene 0.4 Rat >5 g/kg (Tisseran. 1995) 
Camphor 3.61 Mouse 1310 mg/kg (Toxnet 2015a) 
Cappilene N/A N/A  
Carene 0.2 Rat 4800 mg/kg (Vigon. 2015d) 
Carvacrol 80 Rat 810 mg/kg (Spectrum. 2006b) 
Caryophyllene 24.73 N/A  
Caryophyllene oxide N/A N/A  
α-Cedrene 0.28 N/A  
Cineole 10.0-25.0 Mouse 3849 mg/kg (Xu. 2014) 
1,8-Cineol (Eucalyptol) 2.55 Rat 2480 mg/kg (Science Lab. 2013a) 
Corymbolone <0.1 N/A  
Cuminaldehyde 16 Rat 1320 mg/kg (TCI. 2014) 
α-Cuvebene 13.53 N/A  
p-Cymene 1.73 Rat 4750 mg/kg (Toxnet. 2013) 
α-Elemene 3.41 N/A  
Eugenol <0.1 Rat 1930 mg/kg (Science Lab. 2013c) 
Farnesene 2.23 Rat 5628 mg/kg (Spex. 2016) 
α-Humulene 3.68 Rat >48 mg/kg (Drug Future) 
Isoaromadendrene epoxide <0.1 N/A  
cis-Lanceo 0.26 N/A  
Ledene oxide 1.39 N/A  
Limonene 0.7 Rat 5 g/kg (Filipsson. 1998) 
Linalool 2.2 Rat 2790 mg/kg (Karlaganis. 2002) 
Menthol N/A Rat 2900 mg/kg (Science Lab. 2005) 
Menthylacetate N/A Rat > 5000 mg/kg (Vigon. 2015c) 
3-Methylpinocarvone N/A N/A  
Muurolene 0.54 N/A  
Myrsene N/A Rat >5000 mg/kg (Spectrum. 2006a) 
Myrsenol N/A Rat 3600 mg/kg (Vigon. 2015b) 
Ocimene N/A Rat >5 g/kg (Tisseran. 1995) 
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Trans-ocimene <0.1 N/A  
Phellandrine <0.1 Rat 5700 mg/kg (EMD. 2013) 
α-Pinene 1.26 Rat 3700 mg/kg (Santa Cruz. 2008) 
β-Pinene 23.7 Human 0.5-5 g/kg (Toxnet. 2009) 
Pinocampheol N/A N/A  
Trans-pinocarveol 0.43 N/A  
Pinocarvione N/A N/A  
Pinocarvone 0.73 N/A  
Pinocarvylacetate N/A N/A  
Psuedopinene 0.32 Rat 4700 mg/kg (Lewis. 1990) 
α-Selinene 8.21 N/A  
β-Selinene 25 N/A  
Sylvestrene <0.1 N/A  
Terpineol-4 N/A Rat > 2000mg/kg (ECA) 
α-Terpineol <0.1 Rat 5170 mg/kg (Toxnet 2015b) 
Terpinen-4-ol <0.1 Rodent 1.0-4.3 g/kg (Acros. 2009b) 
α-Terpinene N/A Rat 1680 mg/kg (Acros. 2015) 
γ-Terpinene <0.1 Rat 3650 (Sigma. 2016) 
Thymol 80 Rat 980 mg/kg (Santa Cruz. 2010) 
Ulangene N/A N/A  
Note. N/A means not available. 
 
 
 Heavy metals are another potentially toxic material that may be detected in A. annua.   
These elements are taken up through the roots from contaminated soil or water and thus the 
concentrations vary across different agricultural regions. For example, arsenic can produce 
harmful effects in humans with as little as 5 mg consumed orally, causing vomiting and diarrhea 
(Kingston. 1993). The oral human LD50 of arsenic is estimated to be 70-180 mg (Table 3; EPA. 
1978). Cadmium has an oral LD50 in rats of 2,330 mg/kg (ACI Alloys). Zinc toxicity occurs 
from ingestion of >255mg (Toxnet). The oral LD50 of zinc for humans is estimated at 3g/kg 
(Acros, 2009a). Nickel likewise requires a large ingested amount to be dangerous with an oral 
LD50 for rats of >9,000 mg/kg (Acros, 2010). Lead has an oral LD50 in humans of 450 mg/kg 
(CDC, 1994). Long term lead exposure is also a concern. The FDA recommends a maximum 
lead level of 0.1 ppm in candy for example (FDA, 2006). The LD50 of pure mercury is not 
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known but for mercuric chloride, the oral LD50 for rats is 25.9-77.7 mg/kg (DHHS, 1999). Table 
3 shows an example of heavy metal concentrations of plants sampled from Gopeshwar, India 
along with US EPA acceptable limits.  
 
Table 3: Concentration of Heavy Metals by Dry Plant Weight (Negi et al. 2012) 
 
Sample Plant 
Part 
As 
mg/kg 
Cd 
mg/kg 
Zn 
mg/kg 
Ni 
mg/kg 
Pb 
mg/kg 
Hg 
mg/kg 
A. annua Leaves 1.82 0.30 18.00 1.22 1.24 1.60 
 Roots 1.86 0.36 27.00 3.02 1.84 1.92 
Acceptable Limits for Water (mg/L) 
 
EPA limits 
0.01 0.005 5.000 0.100 0.005 0.002 
Acceptable Limits Source: (FDA, 2016) 
 
 
2.5    Dietary Exposure 
As of February 23, 2017, liquid extracts (https://www.swansonvitamins.com/swanson-
premium-full-spectrum-wormwood-425-mg-90-caps) and aerial shoot parts of A. annua in 
capsules (http://www.iherb.com/pr/herb-pharm-artemisia-annua-1-fl-oz-29-6-ml/12681) are 
available for purchase in the U.S. from Swanson Vitamins. The Full-Spectrum Wormwood aerial 
parts supplement is advertised as 425 mg capsules of dried A. annua and has been on the market 
since 2007. A. annua capsules are also sold by Solaray as a dietary supplement 
(http://www.vitacost.com/solaray-sweet-wormwood-100-vegetarian-capsules-2). Capsules of 
98.5% pure artemisinin can purchased from Better Health International and are listed as 
containing no thujone 
(http://www.betterhealthinternational.com/productDetails.asp?prodID=NC55400&utm_medium
=shoppingengine&utm_source=shopzilla). 
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2.6    Self-limiting levels of use 
The dried leaf material is expected to be consumed in 500 mg tablets of dried leaf powder 
with up to 10 tablets per day for five days. The patients that participated in a study that used this 
regimen reported no adverse effects (ICIPE, 2005). The LD50 for A. annua taken as gel capsules 
in mice is 162.5g/kg (Wan et al. 1992), however, that study used crude extracts of the plant and 
not just the dried leaf powder. 
 
2.7    Dietary uses pre 1958 
Sweet Wormwood, despite being bitter tasting to many, is reportedly eaten as part of 
salads in some Asian countries (Tompa, 2008). About 25% of individuals do not perceive the 
plant as tasting bitter and actually find the taste pleasant (Desrosiers and Weathers, 2016). 
 
2.8    Historical use in medicine 
The earliest known use of A. annua is as early as 168 B.C. in China where it is called 
Qing Hao in the Chinese Materia Medica (Hongwen and Shouming, 2002). It was used for 
treating “hemorrhoids, lice, wounds, boils, sores, ‘lingering heat in joints and bones’ as well as 
‘exhaustion due to heat/fevers’” (Hsu, 2006a). The last two ailments are common symptoms of 
malaria so the plant might have been used to treat malaria long before modern times (Hongwen 
and Shouming, 2002). According to the ancient Chinese Materia Medica, the plant was prepared 
by soaking it in water and then wringing it out. This process would expel the juice from the plant 
into the water which was then simply ingested in its entirety (Hsu, 2006b). 
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2.9    Acceptance by Experts 
A. annua is botanically accepted as being a safe plant. It is listed in the Handbook of 
phytochemical constituents of GRAS herbs and other economic plants by James A. Duke and 
even has listed dosages of 30g of dry leaf per day (Duke, 2001). This dosage is 10-30 times 
greater than the maximum anticipated dosage per day for treating malaria. 
 
2.10    GRAS Status for Artemisia genus 
The Artemisia genus of plants already has a GRAS status with the FDA, as long as the 
final product is thujone-free (Appendix A). Thujone is a monoterpene found in a number of 
Artemisia species e.g. A. absinthium, which is used in the production of absinthe. At high enough 
dosages, thujone is a neurotoxin that can lead to convulsions, unconsciousness, and death in 
humans (Cobb, 1922). However, A. annua is a species that contains no thujone and therefore the 
thujone restriction does not limit A. annua use (Tzenkova et al. 2010). 
 
2.11 Conclusions 
 To our knowledge there is no inherent risk to consuming dried A. annua either as a 
supplement or as part of a malarial treatment with the exception of the possible presence of 
heavy metals at concentrations higher than recommended by the FDA.  Such an issue can be 
resolved however, by growing the plants with soil and water that do not contain enough of these 
substances to bioaccumulate to harmful levels by the time the leaves are harvested.  Regular 
testing of the harvested material would also be prudent. This report can be used not only as a 
source to demonstrate the safety of Artemisia annua L. consumption but also potentially as part 
of a future effort to have the FDA specifically recognize A. annua as a GRAS substance. 
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